7 T MRI reveals diffuse iron deposition in putamen and caudate nucleus in CADASIL

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 83, Issue 12, 2012, Pages 1180-1185

  Liem, Michael K ^a   Oberstein, Saskia A J Lesnik ^a   Versluis, Maarten J ^a   Maat Schieman, Marion L C ^a   Haan, Joost ^a,b   Webb, Andrew G ^a   Ferrari, Michel D ^a   Van Buchem, Mark A ^a   Van Der Grond, Jeroen ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RIJNLAND HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CADASIL; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; GENE MUTATION; HETEROZYGOTE; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; IN VIVO STUDY; IRON STORAGE; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PUTAMEN;

ADULT; AUTOPSY; CADASIL; CAUDATE NUCLEUS; CEREBRAL HEMORRHAGE; ECHO-PLANAR IMAGING; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; IRON; IRON METABOLISM DISORDERS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUTATION; PUTAMEN; RECEPTORS, NOTCH; WHOLE BODY IMAGING;

EID: 84869239763     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2012-302545     Document Type: Article

References (16)

1. Milton WJ, Atlas SW, Lexa FJ, et al. Deep gray matter hypointensity patterns with aging in healthy adults: MR imaging at 1.5 T. Radiology 1991;181:715-19.
2. Berg D, Youdim MB. Role of iron in neurodegenerative disorders. Top Magn Reson Imaging 2006;17:5-17. (Pubitemid 46672929)
3. van Es AC, van der Grond J, de Craen AJ, et al. Caudate nucleus hypointensity in the elderly is associated with markers of neurodegeneration on MRI. Neurobiol Aging 2008;29:1839-46.
4. Joutel A, Vahedi K, Corpechot C, et al. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet 1997;350:1511-15. (Pubitemid 28036555)
5. Ruchoux MM, Guerouaou D, Vandenhaute B, et al. Systemic vascular smooth muscle cell impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Acta Neuropathol 1995;89:500-12.
6. Duyn JH, van Gelderen P, Li TQ, et al. High-field MRI of brain cortical substructure based on signal phase. Proc Natl Acad Sci U S A 2007;104:11796-801. (Pubitemid 47175092)
7. Haacke EM, Xu Y, Cheng YC, et al. Susceptibility weighted imaging (SWI). Magn Reson Med 2004;52:612-18. (Pubitemid 39108975)
8. Greenberg SM, Vernooij MW, Cordonnier C, et al. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol 2009;8:165-74.
9. Bartzokis G, Cummings J, Perlman S, et al. Increased basal ganglia iron levels in Huntington disease. Arch Neurol 1999;56:569-74. (Pubitemid 29218152)
10. Cross PA, Atlas SW, Grossman RI. MR evaluation of brain iron in children with cerebral infarction. AJNR Am J Neuroradiol 1990;11:341-8. (Pubitemid 20155071)
11. van Rooden S, Maat-Schieman ML, Nabuurs RJ, et al. Cerebral amyloidosis: postmortem detection with human 7.0-T MR imaging system. Radiology 2009;253:788-96.
12. Zhu WZ, Zhong WD, Wang W, et al. Quantitative MR phase-corrected imaging to investigate increased brain iron deposition of patients with Alzheimer disease. Radiology 2009;253:497-504.
13. Dietrich RB, Bradley WG Jr. Iron accumulation in the basal ganglia following severe ischemic-anoxic insults in children. Radiology 1988;168:203-6.
14. Gutteridge JM. Iron and oxygen radicals in brain. Ann Neurol 1992;(32 Suppl): S16-21.
15. Gaasch JA, Lockman PR, Geldenhuys WJ, et al. Brain iron toxicity: differential responses of astrocytes, neurons, and endothelial cells. Neurochem Res 2007;32:1196-208. (Pubitemid 46817469)
16. Opherk C, Peters N, Holtmannspotter M, et al. Heritability of MRI lesion volume in CADASIL: evidence for genetic modifiers. Stroke 2006;37:2684-9. (Pubitemid 44922526)